NCT03302442View on ClinicalTrials.gov

Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

August 1, 2017

Study Completion Date

October 1, 2017

Conditions
Relapsing-remitting Multiple Sclerosis
Interventions
OTHER

Non interventional study

Not applicable - Non interventional Study

Trial Locations (1)

44093

Nantes University Hospital, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT03302442 - Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis | Biotech Hunter | Biotech Hunter